Large gap with delayed quotes
|
Last quote
01/15/2026
-
02:00:00
|
Bid
01/14/2026 -
21:59:59
|
Bid Volume |
Ask
01/14/2026 -
21:59:59
|
Ask Volume |
|---|---|---|---|---|
|
754.14
-4.77
(
-0.63% )
|
754.06
|
240 |
754.62
|
160 |
Analysis date: 09.01.2026
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 28.10.2025.
Interest
Strong
Strong
Three stars since 02.01.2026.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 02.01.2026 at a price of 776.31.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 04.07.2025.
4wk Rel Perf
13.17%
13.17%
The four-week dividend-adjusted overperformance versus SP500 is 13.17%.
Sensibility
High
High
The stock has been on the high-sensitivity level since 28.10.2025.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.40%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.43%.
Mkt Cap in $bn
84.19
84.19
With a market capitalization >$8bn, REGENERON PHARMA is considered a large-cap stock.
G/PE Ratio
0.89
0.89
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
13.48
13.48
The estimated PE is for the year 2028.
LT Growth
11.54%
11.54%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
18
18
Over the last seven weeks, an average of 18 analysts provided earnings per share estimates.
Dividend Yield
0.47%
0.47%
The twelve month estimated dividend yield represents 6.29% of earnings forecasts.
Beta
53
53
For 1% of index variation, the stock varies on average by 0.53%.
Correlation
0.24
0.24
Stock movements are strongly independent of index variations.
Value at Risk
345.15
345.15
The value at risk is estimated at USD 345.15. The risk is therefore 43.33%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
02.04.2004
02.04.2004